BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND EML4, ENSG00000143924, 27436 AND Prognosis
6 results:

  • 1. Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-ALK and ALK-eml4 in combined treatment of Alectinib and CyberKnife: A case report.
    Li Y; Lu S; Yao P; Huang W; Huang Y; Zhou Y; Yuan Y; Cheng S; Wu F
    Medicine (Baltimore); 2024 Jan; 103(3):e36992. PubMed ID: 38241569
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transformation of NSCLC to SCLC harboring eml4-ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review.
    Lingling X; Maoxi C; Wei Y; Jieting Z; Yuanyuan Y; Ning X
    Lung Cancer; 2023 Dec; 186():107415. PubMed ID: 37907052
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treatment of brain Metastases of Non-Small Cell Lung Carcinoma.
    Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. 68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report.
    Tanriverdi O; Tarimer ML; Pak CD; Uylas S; Alkan A; Celik OI; Kilic RM; Zeybek A
    J Oncol Pharm Pract; 2021 Jun; 27(4):984-989. PubMed ID: 32830600
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
    Duan X; Zhao X; Wang S
    Ann Palliat Med; 2021 May; 10(5):5797-5807. PubMed ID: 32819126
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lung cancer and pregnancy.
    Sarıman N; Levent E; Yener NA; Orki A; Saygı A
    Lung Cancer; 2013 Mar; 79(3):321-3. PubMed ID: 23254266
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.